Catalyst Crew Technologies Corp. (OTC: CCTC) announced Monday the creation of LataMed AI VE, C.A., a Venezuelan operating subsidiary designed to bolster the company’s telehealth regulatory, commercialization, and healthcare deployment initiatives within the country. The move underscores the digital health and artificial intelligence technology company’s strategy to expand its presence in emerging markets, with an initial focus on Latin America.
The subsidiary is expected to serve as a principal localized entity for the phased rollout of Catalyst Crew’s telehealth platform and broader healthcare delivery infrastructure. Management anticipates that operational activities through LataMed AI VE, C.A. may begin in the coming weeks, contingent upon continued regulatory progress, operational readiness, and commercialization planning. The subsidiary will work alongside Inversiones Long 33, C.A., as part of a regional infrastructure strategy aimed at enhancing regulatory flexibility, healthcare service operations, permit management, and long-term scalability.
According to the company, LataMed AI VE, C.A. will support patient onboarding systems, provider coordination, telehealth infrastructure deployment, regulatory compliance, commercialization planning, healthcare analytics integration, and overall operational management within the evolving Latin American healthcare ecosystem. Catalyst Crew continues to advance its telehealth platform development and testing through its interface at https://latamedai.org.
“The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela,” said Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp. “We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution.”
The company is coordinating with Venezuelan health authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader infrastructure and commercialization goals. Catalyst Crew is an AI-driven healthcare technology company focused on scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. Its strategy includes telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
The establishment of LataMed AI VE, C.A. signals Catalyst Crew’s commitment to navigating the complex regulatory landscape in Venezuela, a market with significant healthcare challenges but also potential for digital health adoption. By creating a localized subsidiary, the company aims to accelerate deployment readiness and position itself for broader expansion across Latin America. However, as a development-stage enterprise without current revenue from its new business direction, the company faces risks including financing, regulatory approvals, and successful implementation of its business plan. More information is available in the company’s SEC filings at www.sec.gov.
This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Catalyst Crew Technologies Establishes Venezuelan Subsidiary to Advance Telehealth Deployment.